Академический Документы
Профессиональный Документы
Культура Документы
• Mood disorders
• Anxiety disorders
• Eating disorders
• Chronic pain
• Incontinence
Major and sub-classes
Mood
Depression requiring
treatment 2-4 weeks relief depression
Begin anti-
depressant
SSRIs available
• Citalopram
• Escitalopram
• Fluoxetine
• Fluvoxamine
• Paroxetine
• Sertraline
Indications SSRIs
• Mood disorders
• Anxiety disorders
Off label:
• Premature ejaculation
• Migraine headache,
• Diabetic neuropathy
• Fibromyalgia
SSRI’s Action
1.Normally serotonin,
a brain chemical is
released from a
nerve cell.
2.Serotonin is then
received by the next
nerve cell.
3.Some serotonin is
then reabsorbed into
the 1st nerve cell.
4.Not having enough serotonin may be
associated with depression & anxiety
disorders. SSRI’s block the re-absorption
of serotonin into the 1st nerve cell.
5.This blocking action results in an increased
amount of serotonin being available at the
next nerve cell.
SSRI’s block reuptake of serotonin into
presynaptic neurone
Neurotransmitter
MAO
Dendrite
Axon
Synapse
• Apathy
• Extrapyramidal side effects (EPSEs)
• Increased prolactin levels
• Serotonin syndrome
• Hyponatraemia
• Bruising and bleeding Increased risk of gastrointestinal
bleeding (Loke, Trivedi, & Singh, 2008).
Antidepressant discontinuation symptoms
• F = flu like symptoms
• I = insomnia
• N = nausea
• I = imbalance
• S = sensory disturbances
• H = hyperarousal (anxiety) (Gelenberg, 1998 cited in Carson, 2000, p. 432)
Advantages of SSRI’s
Axon
Dendrite
Dendrite
• Mood disorders
• OCD
• Panic disorder
• Neuralgia (nerve pain) - best available evidence is for
amitriptyline (Saarto & Wiffen, 2007)
• Nocturnal enuresis
TCA Action: 4 actions
MAO
Dendrite
Axon
Synapse
!Example:
!Mirtazapine